AWM
GSK icon

Axxcess Wealth Management’s GSK GSK Stock Holding History

Axxcess Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,621
Closed -$216K – 942
2025
Q2 		$216K Buy
5,621
+175
+3% +$6.69K 0.01% 827
2025
Q1 		$211K Buy
+5,446
New +$199K 0.01% 799
2024
Q4 		– Sell
-5,435
Closed -$222K – 890
2024
Q3 		$222K Sell
5,435
-318
-6% -$13K 0.01% 810
2024
Q2 		$221K Buy
+5,753
New +$242K 0.01% 759

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Axxcess Wealth Management's GSK Position: Q3 2025 in Review

Axxcess Wealth Management sold out of GSK (GSK) in Q3 2025, closing a stake of 5,621 shares — an estimated $216K sold.

Axxcess Wealth Management first reported a position in GSK in Q2 2024 and held it in 4 quarters. The position peaked at $222K in Q3 2024. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Axxcess Wealth Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Axxcess Wealth Management sold 5,621 GSK shares in Q3 2025, an estimated $216K.
  • Axxcess Wealth Management first reported a position in GSK in Q2 2024 and held it in 4 quarters.
  • Axxcess Wealth Management's GSK position peaked at $222K in Q3 2024.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Axxcess Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.